Results 101 to 110 of about 3,054,079 (160)

Integrated analysis of physiological, endogenous phytohormones, and transcriptomics reveals the effects of exogenous CPPPU on sweet potato agronomic traits. [PDF]

BMC Plant Biol
Lin X, Su C, Hu MH, Tang B, Wu C, Zhu H.
europepmc   +1 more source

Advanced cholangiocarcinoma with human epidermal growth factor receptor 2 (HER2) amplification treated with Trastuzumab deruxtecan (T-DXd): A case report. [PDF]

Medicine (Baltimore)
Bao X, Chen Z, Xiong J, Yang Z, Zhang N.
europepmc   +1 more source

New Hybrid Ethylenediurea (EDU) Derivatives and Their Phytoactivity. [PDF]

Int J Mol Sci
Oshchepkov MS, Kovalenko LV, Kalistratova AV, Tkachenko SV, Gorunova ON, Bystrova NA, Kochetkov KA.   +6 more
europepmc   +1 more source

New Directions in <i>Helicobacter pylori</i> Urease Inhibitors: Focusing on Nickel Ions Transfer and Auxiliary Protein Interactions During Urease Maturation. [PDF]

Infect Drug Resist
Chen X, Gou L, Wang Y, Yang J, Dong Y, Xie B, Zhang D.   +6 more
europepmc   +1 more source

Synthesis of New N,N'-Diarylureas and Their Theoretical Study as Cannabinoid-1 Receptor Inhibitors. [PDF]

Chempluschem
Tsemperlidou E, Georgiou N, Tzeli D, Karousis N, Varvounis G.   +4 more
europepmc   +1 more source

Clinical outcomes with first-line tislelizumab plus lenvatinib in unresectable hepatocellular carcinoma: a retrospective analysis. [PDF]

PeerJ
Lin J, Zhou Q, Yao Z, Wang Q, Xu S, Xiong Z, Dang X, Liang H, Liu B.   +8 more
europepmc   +1 more source

Neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma: an investigator-initiated, open-label phase II trial. [PDF]

J Immunother Cancer
Brohl AS, Sondak VK, Wuthrick EJ, Kim Y, Eroglu Z, Markowitz J, Tarhini AA, Fan W, Martin J, Sneed L, Perez MC, Sarnaik A, Harrington M, Neves RI, Gonzalez RJ, Cruse CW, Zager JS, Tsai KY, Khushalani NI.   +18 more
europepmc   +1 more source

Environmental Fate of Linuron Risk Characterization [PDF]

Jessica Twining
core  

Case report: Nephrotic syndrome induced by Lenvatinib treatment in a patient with von Hippel-Lindau syndrome. [PDF]

BMC Nephrol
Zhang S, Li Y, Wen W.
europepmc   +1 more source